# Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

Article · Sylvie Boutin, Virginie Monteilhet, Philippe Veron, Christian Leborgne, Olivier Benvéniste, M. Montus, Carole Masurier

- Archive id: doi:10.1089/hum.2009.182
- Published: 2010-01-22
- Venue: Human Gene Therapy
- DOI: https://doi.org/10.1089/hum.2009.182
- PMID: 20095819
- Citations: 970
- Source URL: https://doi.org/10.1089/hum.2009.182
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Gene & Cell Therapy](https://space-kitty.com/topics/gene-cell-therapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.